Van Berkom & Associates Inc. Sells 26,213 Shares of Privia Health Group, Inc. $PRVA

Van Berkom & Associates Inc. lowered its holdings in Privia Health Group, Inc. (NASDAQ:PRVA) by 0.7% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,685,410 shares of the company’s stock after selling 26,213 shares during the period. Privia Health Group makes up 2.6% of Van Berkom & Associates Inc.’s portfolio, making the stock its 10th biggest position. Van Berkom & Associates Inc. owned about 2.89% of Privia Health Group worth $72,566,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also modified their holdings of PRVA. BlackRock Inc. acquired a new position in Privia Health Group during the second quarter valued at $550,684,000. Rubicon Founders LLC acquired a new stake in Privia Health Group during the 2nd quarter worth about $153,635,863. Bank of New York Mellon Corp acquired a new stake in Privia Health Group during the 2nd quarter worth about $74,425,000. Wellington Management Group LLP boosted its position in Privia Health Group by 850.6% during the 2nd quarter. Wellington Management Group LLP now owns 2,130,289 shares of the company’s stock worth $54,812,000 after acquiring an additional 1,906,187 shares during the period. Finally, Bank of America Corp DE acquired a new stake in Privia Health Group during the 2nd quarter worth about $36,848,000. Institutional investors and hedge funds own 94.48% of the company’s stock.

Analyst Upgrades and Downgrades

PRVA has been the topic of several research analyst reports. Canaccord Genuity Group lifted their target price on Privia Health Group from $32.00 to $33.00 and gave the company a “buy” rating in a research note on Friday. Weiss Ratings reissued a “hold (c)” rating on shares of Privia Health Group in a research report on Tuesday, September 29th. Piper Sandler increased their price target on shares of Privia Health Group from $36.00 to $38.00 and gave the stock an “overweight” rating in a research report on Friday. Zacks Research upgraded shares of Privia Health Group from a “strong sell” rating to a “hold” rating in a report on Wednesday, August 5th. Finally, Citigroup reaffirmed a “buy” rating on shares of Privia Health Group in a research report on Thursday, July 23rd. Nine analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $31.25.

Privia Health Group Trading Up 0.5%

Shares of NASDAQ:PRVA opened at $24.54 on Tuesday. Privia Health Group, Inc. has a 1 year low of $18.92 and a 1 year high of $28.82. The business has a fifty day simple moving average of $21.12 and a 200 day simple moving average of $22.64. The firm has a market cap of $3.13 billion, a price-to-earnings ratio of 94.39 and a beta of 0.76.

Privia Health Group (NASDAQ:PRVA) last issued its earnings results on Thursday, November 5th. The company reported $0.21 EPS for the quarter, beating analysts’ consensus estimates of $0.09 by $0.12. Privia Health Group had a return on equity of 3.52% and a net margin of 1.19%. The firm had revenue of $656.96 million for the quarter, compared to the consensus estimate of $610.72 million. During the same quarter in the previous year, the company posted $0.29 earnings per share. The business’s quarterly revenue was up 13.2% compared to the same quarter last year. On average, sell-side analysts forecast that Privia Health Group, Inc. will post 0.27 EPS for the current year.

Privia Health Group Profile

Privia Health Group, Inc is a physician enablement company that partners with independent medical groups, health systems and other providers. Its technology-enabled platform is designed to help physicians manage their practices and deliver coordinated care, while retaining their clinical independence.

The company provides practice management, technology, care coordination and population health services. It also helps providers participate in value-based care arrangements, which tie payments more closely to the quality and efficiency of care.